Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
Activision Win Is Big for Microsoft---Smaller for Big Tech
Finances

Activision Win Is Big for Microsoft—Smaller for Big Tech

An FTC campaign to rein in tech giants suffers another setback, but will likely persist. Source link

Microsoft Can Close Its $75 Billion Buy of Activision Blizzard, Judge Rules
Business

Microsoft Can Close Its $75 Billion Buy of Activision Blizzard, Judge Rules

The companies can complete the deal before a Federal Trade Commission hearing that is scheduled for August. Source link

Bank of America Ordered to Pay $250 Million Over Wrongful Fees
Finances

Bank of America Ordered to Pay $250 Million Over Wrongful Fees

The CFPB also said the bank withheld credit card rewards and opened accounts without consent. Source link

Sam Altman-Backed Nuclear Startup Is Going Public Through Altman's SPAC
Finances

Sam Altman-Backed Nuclear Startup Is Going Public Through Altman's SPAC

Oklo, which is developing a small modular nuclear reactor, is valued at around $850 million. Source link

Bayou Teche Is an Epicenter of America's Lead Cable Problem
Business

Bayou Teche Is an Epicenter of America's Lead Cable Problem

Southern Louisiana is a prime example of how old phone cables are contaminating soil and water across the U.S., according to a Journal investigation. Source

FDA Approval Isn't Always a Happy Day for Biotech Investors
Business

FDA's OK Isn't Always a Happy Day for Biotech Investors

In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link

Is Work From Home to Blame for Senior Housing's Muted Recovery?
Business

Is Work From Home to Blame for Senior Housing's Muted Recovery?

Markets with high levels of remote work tend to have lower senior-housing occupancy rates. Source link

FDA Approval Isn't Always a Happy Day for Biotech Investors
Finances

FDA Approval Isn't Always a Happy Day for Biotech Investors

In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link